MedTrace Logo

Effectiveness of Low-Level Light Therapy for Vocal Fatigue

NCT07062302 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2025-07-14

No results posted yet for this study

Summary

The goal of this phase 2 clinical trial is to examine the effectiveness of photobiomodulation in patients with vocal fatigue.

The main question it aims to answer is whether photobiomodulation is able to alleviate vocal fatigue in patients with diagnosed vocal fatigue.

Participants will ask to receive photobiomodulation treatment for 12 sessions over a three week period.

Conditions

  • Vocal Fatigue

Interventions

DEVICE

photobiomodulation

The output of the photobiomodulation device is listed as below: * Irradiation size: 15 cm × 10 cm * Dual-wavelength: 660 nm + 850 nm * Optical power density: 10 - 15 mW/cm2 * Dose density: 6J/cm2

Sponsors & Collaborators

  • Chinese University of Hong Kong

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-09
Primary Completion
2024-05-12
Completion
2024-06-12

Countries

  • Hong Kong

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07062302 on ClinicalTrials.gov